Table 6 Multifactorial analysis of COPD patients influencing the COVID-19 vaccination.
From: The status and influencing factors of COVID-19 vaccination in patients with COPD
Variables | β | SE | waldχ2 | P | OR (95%CI) |
|---|---|---|---|---|---|
Ages (years) | |||||
≤ 45 | 1.000 (reference) | ||||
45–55 | − 0.041 | 0.269 | 0.024 | 0.878 | 0.959 (0.566–1.626) |
55–65 | − 0.074 | 0.256 | 0.084 | 0.772 | 0.929 (0.562–1.534) |
65–75 | 0.178 | 0.256 | 0.48 | 0.488 | 1.194 (0.723–1.974) |
75–85 | 0.6 | 0.295 | 4.145 | 0.042 | 1.822 (1.023–3.246) |
> 85 | 0.959 | 0.489 | 3.846 | 0.050 | 2.609 (1.001–6.802) |
Marital status | |||||
Single | 1.000 (reference) | ||||
Married | − 0.481 | 0.357 | 1.811 | 0.178 | 0.618 (0.307–1.245) |
Divorced | − 0.096 | 0.4 | 0.057 | 0.811 | 0.909 (0.415–1.991) |
Widowed | − 0.019 | 0.394 | 0.002 | 0.961 | 0.981 (0.453–2.122) |
Cohabitation | − 0.312 | 0.423 | 0.545 | 0.460 | 0.732 (0.319–1.677) |
Application of non-invasive ventilator | |||||
No | 1.000 (reference) | ||||
Yes | 0.385 | 0.165 | 5.444 | 0.020* | 1.469 (1.063–2.029) |
Combined cardiovascular diseases | |||||
No | 1.000 (reference) | ||||
Yes | 0.434 | 0.135 | 10.382 | 0.001** | 1.544 (1.185–2.010) |
Combined endocrine system diseases | |||||
No | 1.000 (reference) | ||||
Yes | 0.566 | 0.145 | 15.308 | < 0.001*** | 1.762 (1.327–2.339) |
Current physical condition | |||||
Good | 1.000 (reference) | ||||
Fair | 0.148 | 0.165 | 0.799 | 0.371 | 1.159 (0.838–1.603) |
Deteriorating | 0.622 | 0.223 | 7.779 | 0.005** | 1.863 (1.203–2.886) |
Number of acute exacerbations in the last year | |||||
0 time | 1.000 (reference) | ||||
1–2 times | − 0.079 | 0.182 | 0.187 | 0.665 | 0.924 (0.647–1.320) |
3–4 times | 0.526 | 0.21 | 6.283 | 0.012* | 1.693 (1.122–2.555) |
5 times or more | − 0.007 | 0.26 | 0.001 | 0.979 | 0.993 (0.597–1.652) |
Regular use of medication for COPD | |||||
Yes | 1.000 (reference) | ||||
No | 0.305 | 0.14 | 4.78 | 0.029* | 1.357 (1.032–1.784) |
Opinion on the safety of current vaccines | |||||
Very safe | 1.000 (reference) | ||||
Safe | 0.038 | 0.164 | 0.054 | 0.817 | 1.039 (0.753–1.432) |
Unsafe | 1.034 | 0.213 | 23.63 | < 0.001*** | 2.813 (1.854–4.269) |
Very unsafe | 0.795 | 0.395 | 4.056 | 0.044 | 2.215 (1.022–4.802) |
Whether medical personnel recommend vaccination with the COVID-19 vaccine | |||||
Recommend timely vaccination | 1.000 (reference) | ||||
No clear answer | 0.509 | 0.149 | 11.653 | 0.001** | 1.664 (1.242–2.229) |
Not recommended | 1.307 | 0.21 | 38.811 | < 0.001*** | 3.695 (2.449–5.575) |
Are you concerned about adverse reactions before receiving the COVID-19 vaccine? | |||||
No | 1.000 (reference) | ||||
Yes | 0.454 | 0.14 | 10.456 | 0.001*** | 1.575 (1.196–2.074) |
Worried about exacerbation of COPD before receiving the COVID-19 vaccine? | |||||
No | 1.000 (reference) | ||||
Yes | 0.594 | 0.14 | 18.009 | < 0.001*** | 1.811 (1.376–2.382) |
